Clinical guidelines and consensus statements make recommendations on the appropriate treatment and care of myeloma patients based on current available evidence. Their aim is to guide decision making to improve the outcomes for patients, ensure healthcare resources are used efficiently and help reduce variation in practice.

IMWG Guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

This paper provides an update to the first guideline published in 2005 by the International Myeloma Working Group on the management of myeloma patients who are ineligible for high-dose therapy and autologous stem cell transplantation. It includes recommendations on the diagnosis and treatment of these patients together with the management of side-effects of treatment.

Download

IMWG consensus on maintenance treatment in myeloma

Maintaining results of successful induction treatment is an important goal in myeloma and the use of maintenance treatment to achieve this has been investigated for a number of years. Here, members of the International Myeloma Working Group review the relevant data and draw a consensus on maintenance treatment in myeloma.

Download